Tell me everything about jaundice. It’s physiology, biochemistry, medicine

Reading File

Finding Sources

Searching PubMed

"jaundice" AND "bilirubin metabolism"

Reading File

Loading Image

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive content from multiple authoritative textbooks. Let me compile the full answer:

Jaundice: Physiology, Biochemistry, and Medicine

1. Definition and Clinical Detection

Jaundice (icterus) is the yellowish discoloration of the skin, sclera, and mucous membranes caused by deposition of the pigment bilirubin. It becomes clinically visible when total plasma bilirubin exceeds 2-3 mg/dL (34-51 µmol/L). The sclera shows the discoloration most reliably because scleral tissue has a high affinity for bilirubin due to its elastin content. Detection can be harder under fluorescent lighting, which may require higher plasma levels before jaundice is apparent.

Tietz Textbook of Laboratory Medicine, p. 1982
Ganong's Review of Medical Physiology, p. 514

2. Bilirubin Biochemistry: Production to Excretion

A. Bilirubin Production (Prehepatic)

About 80-85% of bilirubin comes from the breakdown of senescent red blood cells (RBCs) in the reticuloendothelial system (spleen, liver, bone marrow). The remaining 15-20% comes from other heme-containing proteins: myoglobin, cytochromes P450, catalase, and peroxidases ("ineffective erythropoiesis").

The pathway:

Heme → Biliverdin: The enzyme heme oxygenase cleaves the heme ring, releasing iron (Fe²⁺), carbon monoxide (CO), and biliverdin (green pigment).
Biliverdin → Bilirubin: The enzyme biliverdin reductase converts biliverdin to bilirubin (yellow pigment). This bilirubin is called unconjugated (indirect) bilirubin - it is lipid-soluble, water-insoluble, and tightly bound to albumin in plasma. It cannot be filtered by the kidneys and does not appear in urine.

B. Hepatic Uptake

Unconjugated bilirubin bound to albumin is transported to the liver. At the hepatocyte sinusoidal surface, it dissociates from albumin and is taken up by specific transport proteins (OATP1B1 and OATP1B3). Inside the hepatocyte, it is bound to intracellular proteins (especially ligandin/glutathione-S-transferase Y) to prevent efflux back into the circulation.

C. Conjugation in the Liver

Inside hepatocytes, unconjugated bilirubin is conjugated with glucuronic acid by UDP-glucuronosyltransferase (UGT1A1) in the smooth endoplasmic reticulum, forming bilirubin mono- and diglucuronide (conjugated/direct bilirubin). This renders it water-soluble, allowing excretion into bile.

D. Canalicular Excretion

Conjugated bilirubin is actively transported across the hepatocyte canalicular membrane into the bile canaliculi by the MRP2 (multidrug resistance protein 2 / ABCC2) transporter. This is the rate-limiting step in bilirubin excretion.

E. Intestinal Fate: Urobilinogen/Stercobilin

In the intestine, bacterial enzymes (beta-glucuronidases from colonic flora) deconjugate and reduce conjugated bilirubin to urobilinogen:

Most urobilinogen is oxidized to stercobilin and excreted in stool, giving stool its brown color.
A small fraction is reabsorbed (enterohepatic circulation), returned to the liver, and re-excreted.
A tiny fraction escapes into the systemic circulation and is filtered by the kidneys, excreted as urobilinogen in urine.

In complete bile duct obstruction: No bilirubin reaches the gut → no urobilinogen/stercobilin → pale/acholic stools and absent urine urobilinogen. Conjugated bilirubin backs up into blood, and because it is water-soluble, it spills into urine → dark (tea-colored) urine.

Ganong's Review of Medical Physiology, pp. 513-514
Tietz Textbook of Laboratory Medicine, p. 1982
Schwartz's Principles of Surgery, p. 1381

3. Classification of Jaundice

Jaundice is classified by where in the metabolic pathway the dysfunction occurs:

Type	Location	Bilirubin Type Elevated	Urine Bilirubin	Urine Urobilinogen	Stool Color
Prehepatic	Before liver	Unconjugated (indirect)	Absent	Increased	Normal/dark
Intrahepatic	Within liver	Both (mixed)	Present	Variable	Variable
Posthepatic	After liver (obstruction)	Conjugated (direct)	Present (dark urine)	Absent	Pale/acholic

4. Prehepatic Jaundice

Caused by excessive bilirubin production overwhelming the liver's conjugation capacity.

Inherited hemolytic disorders:

Hereditary spherocytosis
Sickle cell anemia
Thalassemia
G6PD deficiency
Pyruvate kinase deficiency

Acquired hemolytic disorders:

Microangiopathic hemolytic anemia (HUS, TTP)
Paroxysmal nocturnal hemoglobinuria (PNH)
Immune-mediated hemolysis (warm/cold autoimmune, drug-induced)
Infections: malaria, babesiosis
Mechanical trauma (prosthetic heart valves)

Other causes:

Ineffective erythropoiesis: cobalamin, folate, or iron deficiency
Resorption of large hematomas
Massive blood transfusion

In hemolytic disorders, serum bilirubin rarely exceeds 5 mg/dL unless there is concurrent hepatic dysfunction. An important complication: chronic hemolysis predisposes to pigmented (calcium bilirubinate) gallstones, so choledocholithiasis must be considered when bilirubin rises sharply in these patients.

Drugs that impair hepatic bilirubin uptake (causing unconjugated hyperbilirubinemia): rifampin, probenecid, atazanavir, certain cephalosporins and penicillins.

Harrison's Principles of Internal Medicine 22E, p. 366-367

5. Intrahepatic Jaundice

A. Hereditary/Genetic Disorders of Bilirubin Metabolism

Unconjugated hyperbilirubinemia (conjugation defects):

Syndrome	Mechanism	Bilirubin Level	Clinical Features
Gilbert's syndrome	Reduced UGT1A1 promoter activity (10-35% of normal)	<6 mg/dL, fluctuating	Benign; 3-7% of population; triggered by fasting, stress, illness, alcohol; may be protective
Crigler-Najjar type II	UGT1A1 mutations, <10% enzyme activity	6-25 mg/dL	Survives into adulthood; phenobarbital lowers levels
Crigler-Najjar type I	Complete absence of UGT1A1	>20 mg/dL	Fatal in infancy without treatment; kernicterus; liver transplant required

Conjugated hyperbilirubinemia (excretion defects):

Syndrome	Defect	Features
Dubin-Johnson syndrome	Mutation in MRP2 (ABCC2) - blocks canalicular bilirubin excretion	Darkly pigmented liver (polymerized epinephrine metabolites), otherwise benign; hepatomegaly
Rotor syndrome	Deficiency of OATP1B1 and OATP1B3 (hepatic reuptake transporters)	Similar to Dubin-Johnson but no liver pigmentation; both benign

B. Hepatocellular Disease

Any condition that damages hepatocytes impairs both conjugation and excretion. Common causes:

Viral hepatitis (A, B, C, D, E; also EBV, CMV)
Alcoholic hepatitis / alcoholic liver disease
Non-alcoholic fatty liver disease (NAFLD) / steatohepatitis
Drug-induced liver injury (DILI): acetaminophen (commonest), isoniazid, statins, herbal preparations
Autoimmune hepatitis
Wilson's disease (in patients <40 years)
Hemochromatosis
Acute liver failure (any cause)
Ischemic hepatitis ("shock liver") from hypoperfusion

Lab pattern: ALT/AST elevated out of proportion to alkaline phosphatase (hepatocellular pattern).

C. Intrahepatic Cholestasis

Impaired bile flow within the liver without extrahepatic obstruction:

Primary biliary cholangitis (PBC): autoimmune destruction of intrahepatic bile ducts; anti-mitochondrial antibody (AMA) positive
Primary sclerosing cholangitis (PSC): fibro-inflammatory stricturing of bile ducts; strongly associated with IBD
Drug-induced cholestasis: anabolic steroids, oral contraceptives, chlorpromazine
Intrahepatic cholestasis of pregnancy
Sepsis-associated cholestasis

Lab pattern: Alkaline phosphatase and GGT elevated out of proportion to ALT/AST (cholestatic pattern).

Robbins & Kumar Basic Pathology, p. 2128
Harrison's Principles of Internal Medicine 22E, pp. 367-370

6. Posthepatic (Obstructive) Jaundice

Caused by mechanical obstruction of the bile duct system (biliary tree), preventing bile flow into the duodenum.

Intrinsic Causes:

Choledocholithiasis (most common) - stones in the common bile duct; can range from mild right upper quadrant pain to ascending cholangitis (Charcot's triad: fever/rigors, RUQ pain, jaundice; Reynolds' pentad adds hypotension and altered mental status)
Cholangiocarcinoma (Klatskin tumor at the hilum)
Benign biliary strictures (post-operative, post-inflammatory)
IgG4-associated cholangitis (responsive to steroids - must differentiate from PSC)
PSC (with extrahepatic component)
Ampullary carcinoma (highest surgical cure rate among periampullary tumors)
AIDS cholangiopathy (CMV, cryptosporidia)

Extrinsic Causes:

Pancreatic cancer (head of pancreas causing "painless jaundice" - classic presentation)
Gallbladder cancer
Chronic pancreatitis (stricture of distal CBD)
Pancreatic pseudocyst
Hilar lymphadenopathy from metastases
Surgical complications: clip injuries, retained stones, ischemic bile duct injury
Schwartz's Principles of Surgery, p. 1381

7. Morphology of Cholestasis (Pathology)

Microscopically, both obstructive and non-obstructive cholestasis show:

Bile plugs: elongated green-brown plugs in dilated canaliculi
Feathery degeneration: bile droplets accumulating in hepatocytes, giving a foamy appearance
Kupffer cell activation: phagocytose extravasated bile after canalicular rupture
Occasional apoptotic hepatocytes

In prolonged obstruction, secondary changes include: portal tract edema, neutrophilic infiltration, proliferation of bile ductules ("ductular reaction"), and eventually biliary fibrosis/cirrhosis.

Robbins & Kumar Basic Pathology, pp. 2128-2140

8. Neonatal Jaundice

Physiologic jaundice of the newborn occurs in almost all neonates because hepatic UGT1A1 activity does not fully mature until ~2 weeks of age. This causes transient unconjugated hyperbilirubinemia, which can be worsened by breastfeeding (breast milk contains bilirubin-deconjugating enzymes).

Treatment: Phototherapy with blue light (wavelength ~460 nm) converts bilirubin to water-soluble photoisomers (lumirubin, configurational isomers) that are excreted in urine and bile without needing conjugation. Exchange transfusion is used in severe cases.

Pathological neonatal jaundice (beyond 2 weeks, or very high levels): Think Crigler-Najjar, biliary atresia, neonatal hepatitis, metabolic disorders.

Kernicterus: Unconjugated bilirubin (>20 mg/dL in neonates) crosses the immature blood-brain barrier and deposits in the basal ganglia and brainstem, causing permanent neurologic damage (cerebral palsy, hearing loss, intellectual disability).

Robbins & Kumar Basic Pathology, p. 2118

9. Clinical Evaluation of Jaundice

Diagnostic Flowchart (Harrison's, Fig. 52-1):

Diagnostic flowchart for evaluating jaundice - from history/labs through to biopsy/MRCP depending on bilirubin type and pattern

Evaluation of the patient with jaundice. The algorithm branches from lab findings into isolated bilirubin elevation vs. elevation with other liver tests, then further subdivides by direct vs. indirect and hepatocellular vs. cholestatic patterns.

History - Key Questions:

Drug exposure: prescribed, OTC, herbal/supplements, anabolic steroids (commonest cause of DILI)
Alcohol use history
IV drug use, tattoos, sexual history (hepatitis B/C risk)
Travel history (malaria, hepatitis E in endemic areas)
Family history (hereditary conditions)
Associated symptoms: pain (RUQ suggests choledocholithiasis; painless jaundice suggests malignancy), fever (infection, cholangitis), pruritus (cholestasis), weight loss (malignancy), dark urine + pale stools (obstructive pattern)

Physical Examination:

Scleral icterus: earliest sign
Hepatomegaly: hepatitis, infiltration, congestion
Splenomegaly: portal hypertension, hemolysis
Murphy's sign: cholecystitis
Courvoisier's sign: palpable, non-tender gallbladder in the setting of painless jaundice suggests malignant obstruction (not gallstones, which cause a shrunken, fibrotic GB)
Stigmata of chronic liver disease: spider nevi, palmar erythema, gynecomastia, caput medusae, asterixis
Xanthomas/xanthelasmas: chronic cholestasis
Lymphadenopathy: infection, lymphoma, metastases

Laboratory Tests:

Test	Prehepatic	Hepatocellular	Cholestatic/Obstructive
Total bilirubin	Elevated	Elevated	Elevated
Direct (conjugated)	Normal (<15%)	Elevated	Elevated
Indirect (unconjugated)	Elevated	Elevated	Normal/mildly elevated
ALT/AST	Normal	Markedly elevated	Mildly elevated
Alkaline phosphatase	Normal	Mildly elevated	Markedly elevated
GGT	Normal	Elevated	Markedly elevated
Albumin	Normal	Low (chronic)	Normal (early)
Prothrombin time	Normal	Prolonged	Prolonged (corrects with Vit K in obstruction)
Urine bilirubin	Absent	Present	Present
Urine urobilinogen	Elevated	Variable	Absent
Haptoglobin	Decreased	Normal	Normal
LDH	Elevated	Elevated	Normal

Imaging:

Ultrasound (first-line): identifies dilated bile ducts (suggesting obstruction), gallstones, liver parenchymal changes. Sensitivity ~60% for choledocholithiasis.
CT abdomen: better for pancreatic masses, lymphadenopathy, hepatic lesions.
MRCP (Magnetic Resonance Cholangiopancreatography): non-invasive, excellent visualization of biliary tree - preferred for suspected choledocholithiasis when US is negative.
ERCP (Endoscopic Retrograde Cholangiopancreatography): both diagnostic and therapeutic - can remove stones, place stents, sample strictures. Reserved for when intervention is anticipated.
EUS (Endoscopic Ultrasound): excellent for ampullary lesions, distal CBD stones, pancreatic head masses.
Liver biopsy: definitive for intrahepatic cholestasis, autoimmune hepatitis, unexplained hepatocellular disease.

Harrison's Principles of Internal Medicine 22E, pp. 366-371
Schwartz's Principles of Surgery, pp. 1381-1382

10. Complications of Jaundice

Pruritus

Caused primarily by cholestasis. Bile acid accumulation in the skin was historically thought to be the cause, but current evidence points to endogenous opioids and lysophosphatidic acid as the main mediators. Treatment: cholestyramine (bile acid resin), rifampicin, naltrexone (opioid antagonist), SSRI (sertraline), antihistamines.

Coagulopathy

Bile is required for absorption of fat-soluble vitamins, including Vitamin K. Obstructive jaundice impairs Vitamin K absorption → decreased synthesis of clotting factors II, VII, IX, X. In obstruction, PT normalizes with IV Vitamin K; in hepatocellular failure, it does not (because the liver cannot synthesize the factors even with adequate Vit K).

Malabsorption

Fat-soluble vitamin deficiencies (A, D, E, K), steatorrhea.

Kernicterus (in neonates)

Unconjugated bilirubin neurotoxicity - see Section 8.

Biliary cirrhosis

Prolonged intrahepatic or extrahepatic obstruction → secondary biliary cirrhosis, portal hypertension, liver failure.

11. Global Considerations

In developed countries, the most common causes of new-onset jaundice are extrahepatic biliary obstruction (choledocholithiasis, malignancy) and drug-induced liver injury.

In developing countries, infections remain the leading cause: malaria, viral hepatitis A and E, leptospirosis, typhoid fever, viral hemorrhagic fevers, and parasitic infections (schistosomiasis, clonorchiasis, ascariasis).

Acute liver failure is signaled by jaundice + encephalopathy + coagulopathy with no prior liver disease - this is a medical emergency requiring urgent liver transplant evaluation.

Harrison's Principles of Internal Medicine 22E, p. 370

12. Key Drug-Induced Causes (Summary)

Drug	Mechanism
Rifampin, probenecid, atazanavir	Inhibit hepatic bilirubin uptake → unconjugated hyperbilirubinemia
Acetaminophen (overdose)	Hepatocellular necrosis (via NAPQI toxicity)
Isoniazid, pyrazinamide	Hepatocellular injury
Anabolic steroids, OCP	Intrahepatic cholestasis
Chlorpromazine	Cholestatic jaundice
Phenobarbital	Induces UGT1A1 (used therapeutically in Crigler-Najjar type II)

Recent Evidence (PubMed, 2025-2026)

A 2025 review in American Family Physician (PMID: 39823630) outlines a systematic approach to jaundice evaluation in adults, consistent with the framework above.
A 2026 review in Pediatric Research (PMID: 40973744) covers translational perspectives on bilirubin biology, noting emerging evidence for bilirubin's cytoprotective and antioxidant roles at mild elevations.
A 2025 review in Int J Mol Sci (PMID: 41226827) provides updated data on bilirubin photoisomers in neonatal jaundice, relevant to phototherapy optimization.

Sources consulted:

Harrison's Principles of Internal Medicine, 22nd Ed. (2025) - Chapter 52
Schwartz's Principles of Surgery, 11th Ed.
Ganong's Review of Medical Physiology, 26th Ed.
Robbins & Kumar Basic Pathology
Tietz Textbook of Laboratory Medicine, 7th Ed.
Sleisenger and Fordtran's Gastrointestinal and Liver Disease

This is a shared conversation. Sign in to Orris to start your own chat.